Wenjia Yang
-
- Diabetes Treatment and Management 38
- Diabetes Management and Research 16
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Pharmacology top 10%
- Pharmacology and Obesity Treatment 6
- Orthopedics and Sports Medicine top 10%
- Obstetrics and Gynecology top 10%
- Nephrology top 10%
-
- Metabolism, Diabetes, and Cancer 16
-
- Pancreatic function and diabetes 9
- Lipoproteins and Cardiovascular Health 4
-
- Peptidase Inhibition and Analysis 6
- Journals
- PLoS ONE (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Wenjia Yang
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 642
- Pharmacology 120
- Orthopedics and Sports Medicine 56
- Obstetrics and Gynecology 50
- Nephrology 41
Countries citing papers authored by Wenjia Yang
This map shows the geographic impact of Wenjia Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjia Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjia Yang more than expected).
Fields of papers citing papers by Wenjia Yang
This network shows the impact of papers produced by Wenjia Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjia Yang. The network helps show where Wenjia Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjia Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 24 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 80 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 43 | |
| 18 | 2017 | 47 | |
| 19 | 2016 | 20 | |
| 20 | 2013 | 6 |
About Wenjia Yang
Wenjia Yang is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (38 papers), Diabetes Management and Research (16 papers), Metabolism, Diabetes, and Cancer (16 papers), Pancreatic function and diabetes (9 papers), Pharmacology and Obesity Treatment (6 papers), Peptidase Inhibition and Analysis (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (642 citations), Pharmacology (120 citations) and Orthopedics and Sports Medicine (56 citations). Wenjia Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiaoling Cai, Linong Ji, Xueyao Han, Xueying Gao, Yifei Chen, Fang Lv, Chu Lin, Linong Ji, Simin Zhang and Lingli Zhou. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.